Caffeine isn’t just for morning energy. As an Active Pharmaceutical Ingredient, it plays crucial roles in combination analgesics, migraine medications, neonatal care, cosmetics, alertness products. Farmson Basic Drugs has expanded into producing high-quality Caffeine API, bringing the same discipline and quality that made its Paracetamol APIs trusted. 

Farmson’s caffeine is produced through a multi-step chemical process (seven distinct chemical conversions), with isolation of four key intermediates in the process. These intermediates are monitored so that impurities (including genotoxic or nitrosamine types) are controlled from early stages, not just at final purification. Purity is critical in pharma use. 

Physical properties matter too polymorph stability, particle size, etc. Farmson provides caffeine in Polymorph Form II, a stable reproducible form, and offers various particle sizes depending on customer needs. Validated cleaning procedures, GMP/EUGMP guidelines, and compliance with IP/EP/USP/JP help ensure regulatory safety.

Scale is built in: Farmson capacities are designed to produce up to ~600 MT per month, though starting at around 300 MT with plans to scale. That ensures ability to meet large orders for international markets. And Farmson emphasizes traceability, documentation, and regulatory readiness important for customers in regulated markets.